EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Review of Next-Generation Sequencing Technologies and Their Impact on Clinical Research: Assessing Clinical Efficacy and Cost-Effectiveness

Pratibha Mambatta Sankaranarayanan, Saranya Kanukollu, Anand Babu Vangala, Rajani Kanth Vangala, Pramod Nair

Trends in Current Biology · 2024

DOI: 10.14719/tcb.3569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Current Biology, 2024. Verfasst von Pratibha Mambatta Sankaranarayanan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In contrast to microarray methods, sequence-based technologies directly determine the nucleic acid sequence. A number of modern sequencing technologies are referred to collectively as "next-generation sequencing" (NGS), often known as "high-throughput sequencing." Compared to conventional Sanger sequencing, NGS gives orders of magnitude more data at a much lower ongoing cost. These new technologies allow for much faster and more affordable sequencing of DNA and RNA, revolutionizing the study of genomics and molecular biology. Technical improvements in NGS sequencing methods have rapidly increased sequencing volume to several billion nucleotides within a short period and at a reasonable cost. Currently, NGS is developing into a molecular microscope that is permeating almost all areas of biological research. The last ten years have seen the development of NGS platforms and methodologies, and the quality of the sequences has increased to the point where NGS is now utilized in human clinical diagnosis. Due to significant cost reductions and greater community acceptance of NGS, the utilization of NGS techniques in studying clinical trials has significantly increased. NGS is a useful tool for detecting mutations in people with cancer and genetic abnormalities. To ascertain whether NGS can cost-effectively improve patient outcomes, more thorough cost-effectiveness studies of NGS applied to patient care management are required.

Zitieren

APA

Sankaranarayanan, P. M., Kanukollu, S., Vangala, A. B., Vangala, R. K., & Nair, P. (2024). A Review of Next-Generation Sequencing Technologies and Their Impact on Clinical Research: Assessing Clinical Efficacy and Cost-Effectiveness. Trends in Current Biology. https://doi.org/10.14719/tcb.3569

Vancouver

Sankaranarayanan PM, Kanukollu S, Vangala AB, Vangala RK, Nair P. A Review of Next-Generation Sequencing Technologies and Their Impact on Clinical Research: Assessing Clinical Efficacy and Cost-Effectiveness. Trends in Current Biology. 2024. doi:10.14719/tcb.3569

BibTeX
@article{Sankaranarayanan2024,
  author = {Sankaranarayanan, Pratibha Mambatta and Kanukollu, Saranya and Vangala, Anand Babu and Vangala, Rajani Kanth and Nair, Pramod},
  title = {A Review of Next-Generation Sequencing Technologies and Their Impact on Clinical Research: Assessing Clinical Efficacy and Cost-Effectiveness},
  journal = {Trends in Current Biology},
  year = {2024},
  doi = {10.14719/tcb.3569}
}
Kostenlos starten →